The Pharmaceutical Market: Brazil

News provided by

May 29, 2012, 06:24 ET

NEW YORK, May 29, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Pharmaceutical Market: Brazil

http://www.reportlinker.com/p0203114/The-Pharmaceutical-Market-Brazil.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical

Espicom's in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.

TABLE OF CONTENTS

Snapshot: Strategic Espicom Analysis 2

Snapshot: Key Data Projections 3

MACROENVIRONMENT 4

POLITICAL 4

ECONOMIC5

Projections 5

LEGAL6

Patent Rejection of Tenofovir 6

Compulsory Licence for Efavirenz 7

DEMOGRAPHIC 8

Projections 8

Demographic Indicators9

Birth Rate 9

Death Rate 9

Infant Mortality 9

Life Expectancy at Birth 9

EPIDEMIOLOGY 10

DISEASE BURDEN 10

DISEASE PREVALENCE11

Communicable Diseases 11

HIV/AIDS 11

Malaria 12

Non-Communicable Diseases 12

Anaemia 12

Cancer 12

Vaccination 13

HEALTHCARE - ACCOMPANYING HEALTH STATISTICS 14

ORGANISATION 14

Main World Bank Health-Related Projects 14

National AIDS/SUS Programme 14

QUALISUS-REDE Brazil Health Network Formation and Quality Improvement Project 14

Second Family Health Extension Adaptable Lending Project 14

INSURANCE15

EXPENDITURE 16

Projections 16

Public Health Expenditure17

Federal Health Expenditure 17

INFRASTRUCTURE 18

Healthcare Establishments 18

SERVICES 19

Inpatient Care Analysis19

Ambulatory Care Analysis 20

WORKFORCE 21

Physician Projections21

Other Workforce 21

REGULATORY AFFAIRS 22

INTERNATIONAL DEVELOPMENTS 22

MERCOSUR Regulation22

Agreement with the FDA22

NATIONAL REGULATION 22

MARKETING REGISTRATION 23

Registration of APIs23

Exemptions 24

IMPORTS 24

CLINICAL TRIALS24

LABELLING & PACKAGING 25

QUALITY CONTROL 26

ADVERTISING26

TRACEABILITY 26

PHARMACY REGULATION27

Regulation of Technical Responsibilities 27

Regulation of Antibiotic Drug Data 27

Regulation of Dispensing Practices 27

PRICING & REIMBURSEMENT 28

Drug Price Authority 28

Drug Price Readjustments 28

Drug Price Control 29

The Tax Substitution System30

REIMBURSEMENT 30

PFPB 31

DISTRIBUTION CHANNELS 32

DRUG WHOLESALING 32

Distribution Trade Associations 32

ABAFARMA 32

ABRADILAN 33

Distributors 35

Athos Farma35

Panpharma 35

Profarma36

Santa Cruz 37

DRUG RETAILING 38

Pharmacy & Drug Store Chains 38

Pharmacy Chain Associations 41

ABRAFARMA 41

ASSIFARMA 42

FEBRAFAR 43

Pharmacy Chains 44

Brazil Pharma 44

Droga Raia45

Drogaria Araújo45

Drogaria Sao Paulo45

Drogarias Pacheco 45

Drogasil 46

Drogasmil 46

Farmácias Pague Menos 47

Panvel Farmácias 48

Hypermarkets48

MARKET ANALYSIS 49

SIZE 49

Projections 49

Historical Figures 51

Structure 53

Pharmacy Sales 53

Public Sales 54

PRODUCT DEVELOPMENT 55

Private Product Development 55

Public Product Development 55

MANUFACTURING 56

Manufacturing Using CNAE 2 0 56

Manufacturing Using CNAE 1 0 61

TRADE 65

Exports 65

Imports 67

Balance of Trade 72

COMPETITION 73

TRADE ASSOCIATIONS 73

ALANAC 73

ALFOB 74

INTERFARMA 75

SINDUSFARMA 76

TRADE FAIRS 76

ABRADILAN FARMA & HPC 76

ECONOFARMA 76

EXPO FARMÁCIA 76

EXPO PHARMA 76

FCE PHARMA 76

Pharmanager 76

COMPANY INTELLIGENCE 77

Foreign Producers 77

Abbott 77

AstraZeneca77

Bayer 78

Boehringer Ingelheim 78

Daiichi-Sankyo 79

GlaxoSmithKline 80

Johnson & Johnson80

Merck 81

Merck Sharp & Dohme82

Novartis 83

Novo Nordisk 84

Nycomed84

Pfizer 85

Roche86

Sanofi87

Servier 88

Zambon 88

Local Producers89

Aché 89

Apsen90

Biolab 91

Cimed 91

Cristália 92

EMS 93

Eurofarma 95

Hypermarcas 98

Libbs Farmacêutica 100

União Química101

Competitive Strategies 102

OTC PHARMACEUTICALS 105

MARKET SIZE 105

COMPETITION 105

Trade Association 105

ABIMIP 105

Competitive Strategies 106

GENERIC PHARMACEUTICALS 107

REGULATION 107

Registration of Generic Medicines 108

MARKET SIZE 108

Private Pharmacy Sector 108

Patent Expiries109

COMPETITION110

Trade Association 110

Pró-Genéricos 110

Competitive Strategies 110

BIOLOGICS & BIOSIMILARS 113

MACROENVIRONMENT 113

REGULATION 113

RDC No 53/2011 114

RDC No 55/2010 114

MARKET 114

Public Vaccine Sector 114

COMPETITION115

Trade Association 115

BrBiotec 115

Foreign Company Intelligence 116

Amgen 116

GlaxoSmithKline 116

Novartis 116

Local Company Intelligence 116

CPPI 116

Biomm 116

Blau 117

Cristália 117

Eurofarma 117

Hebron 117

Hemobrás 117

Instituto Butantan 118

PharmaPraxis 118

CONCLUSIONS: OPPORTUNITIES & CHALLENGES 120

Strategic Espicom Analysis 120

MACROENVIRONMENT 120

EPIDEMIOLOGY 120

HEALTHCARE120

REGULATORY AFFAIRS121

PRICING & REIMBURSEMENT 122

DISTRIBUTION CHANNELS 122

MARKET 122

COMPETITION 123

OTC PHARMACEUTICALS 123

GENERIC PHARMACEUTICALS123

BIOLOGICS & BIOSIMILARS 124

Radar Analysis 126

SWOT Analysis 126

DIRECTORY 127

COMPETITION127

Foreign Biologic Companies 127

Foreign Pharmaceutical Companies 127

Local Biologic Companies127

Local Pharmaceutical Companies 127

GOVERNMENT ORGANISATIONS 128

TRADE ASSOCIATIONS 128

List of Tables

Espicom Analysis of the Pharmaceutical Market, 2011 2Key Data Projections, 2011-2016 3Political Landscape, 2011 4Regional Ranking of Projected Economies, 2016 5Projected Economy, 2011-2016 5Regional Ranking of Projected Demographics, 2016 8Projected Demographics, 2011-2016 8Projected Demographic Indicators, 2010-2016 9Deaths by Selected Cause, 2000-2008 10Infectious Diseases, 2001-2009 11Health Insurers, 2000-June 2010 15Beneficiaries with Medical Services (With/Without Odontology) by Contract Type, 2000-June 2010 15Regional Ranking of Projected Health Expenditure, 2016 16Projected Health Expenditure, 2011-2016 16Healthcare Establishments by Type, 2005-September 2010 18SUS Hospital Admissions by Specialty, 2000-2009 19SUS Ambulatory Procedures by Type, 2009 20Approved SUS Ambulatory Procedures by Provider, 2000-2009 20Regional Ranking of Projected Physicians, 2016 21Projected Physicians, 2011-2016 21Members of ABAFARMA, 2011 32Members of ABRADILAN, 2010 33Profarma's Gross Sales by Type, QIII 2010 vs QIII 2011 (R$ Million) 36Profarma's Net & Gross Sales, 2005-2010 (R$ Million) 36Profarma's Distribution Centres by Location, 2011 37ABRAFARMA's Ranking of Pharmacy Chains by Sales, 2008-2010 39ABRAFARMA's Ranking of Pharmacy Chains by Number of Outlets, 2008-2010 40ABRAFARMA's Financial Indicators, 2008-2010 41Members of ABRAFARMA, 2011 42Members of ASSIFARMA, 2011 42Members of FEBRAFAR by Region, 2011 43 Drogasil's Financial Indicators, 2004-2010 (R$ Million) 46Pague Menos' Sales, 2000-2011 47Regional Ranking of Projected Pharmaceutical Markets at Retail Prices, 2016 49Projected Pharmaceutical Market at Retail Prices, 2011-2016 50Historical Pharmaceutical Market at Retail Prices, 1995-2010 51Historical Pharmaceutical Market at Manufacturers' Prices, 1997-2009 52Pharmacy Sales Value & Volume at Manufacturers' Prices, 2006-2010 53Pharmacy Sales by Leading Company, 2010 53Pharmaceutical Production Indicators by Company Size, 2007-2009 57Pharmaceutical Production Indicators by Manufacturing Unit Size, 2007-2009 58State Pharmaceutical Production Indicators by Manufacturing Units with 5+ Employees, 2009 59State Pharmaceutical Production Indicators by Manufacturing Units with 5+ Employees, 2009 (%) 60Pharmaceutical Manufacturing Units by Leading State, 2002-2007 61Pharmaceutical Workforce by Leading State, 2002-2007 62Pharmaceutical Gross Production by Leading State, 2002-2007 (R$ Million) 63Pharmaceutical Gross Production by Companies with 30+ Employees, 2007 (R$ 000s) 63Pharmaceutical Gross Production by Manufacturing Units with 30+ Employees, 2007 (R$ 000s) 64Pharmaceutical Exports by Category, 1995-2010 (US$000s) 65Pharmaceutical Exports by Country/Region, 2010 (US$000s) 66Pharmaceutical Imports by Category, 1995-2010 (US$000s) 67Imports of Raw Materials by Country/Region, 2010 (US$000s) 69Imports of Antisera & Vaccines by Country/Region, 2010 (US$000s) 70Imports of Medicaments by Country/Region, 2010 (US$000s) 71Balance of Pharmaceutical Trade, 1995-2010 (US$000s) 72Members of ALANAC, 2011 73Members of ALFOB, 2011 74Members of INTERFARMA, 2011 75Hypermarcas' Major Acquisitions, 2005-2011 99Hypermarcas' Net Sales by Division, 2009-2010 (R$ Million) 99Members of ABIMIP, 2011 105Cumulative Active Ingredients, Registrations & Presentations of Generics, 2000-April 2011 108Pharmacy Generic Sales by Value & Volume, 2006-2010109Top-12 Leading Brands Losing Patent, 2012 109Members of Pró-Genéricos, 2011 110Espicom Analysis of the Pharmaceutical Market, 2011 125SWOT Analysis of the Pharmaceutical Market, 2011126

List of Charts

Regional Comparison of Top 4 Projected Pharmaceutical Markets at Retail Prices, 2016 49

Regional Comparison of Projected Pharmaceutical Market Share at Retail Prices, 2016 50

Historical Pharmaceutical Market at Retail Prices, 1995-2010 51

Historical Pharmaceutical Market at Manufacturers' Prices, 1997-2009 52

Pharmaceutical Monthly Production Index, January 2008-August 2011 56

Number of Pharmaceutical Producers, 1997-2007 61

Pharmaceutical Workforce, 1997-2007 62

Pharmaceutical Gross Production, 1997-2007 63

Pharmaceutical Gross Production by Manufacturing Type, 2007 (%) 64

Pharmaceutical Exports, 1995-2010 (US$ Millions) 65

Pharmaceutical Imports, 1995-2010 (US$ Millions) 67